283 related articles for article (PubMed ID: 15578376)
1. Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.
Cherry JD; Chang SJ; Klein D; Lee M; Barenkamp S; Bernstein D; Edelman R; Decker MD; Greenberg DP; Keitel W; Treanor J; Ward JI
Clin Infect Dis; 2004 Dec; 39(11):1715-8. PubMed ID: 15578376
[TBL] [Abstract][Full Text] [Related]
2. Immune responses and antibody decay after immunization of adolescents and adults with an acellular pertussis vaccine: the APERT Study.
Le T; Cherry JD; Chang SJ; Knoll MD; Lee ML; Barenkamp S; Bernstein D; Edelman R; Edwards KM; Greenberg D; Keitel W; Treanor J; Ward JI;
J Infect Dis; 2004 Aug; 190(3):535-44. PubMed ID: 15243929
[TBL] [Abstract][Full Text] [Related]
3. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity of a single dose of reduced-antigen acellular pertussis vaccine in a non-vaccinated adolescent population.
Knuf M; Zepp F; Meyer C; Grzegowski E; Wolter J; Riffelmann M; Wirsing von König CH
Vaccine; 2006 Mar; 24(12):2043-8. PubMed ID: 16356597
[TBL] [Abstract][Full Text] [Related]
5. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT).
Ward JI; Cherry JD; Chang SJ; Partridge S; Keitel W; Edwards K; Lee M; Treanor J; Greenberg DP; Barenkamp S; Bernstein DI; Edelman R;
Clin Infect Dis; 2006 Jul; 43(2):151-7. PubMed ID: 16779740
[TBL] [Abstract][Full Text] [Related]
6. Serologic response and antibody-titer decay in adults with pertussis.
Heininger U; Cherry JD; Stehr K
Clin Infect Dis; 2004 Feb; 38(4):591-4. PubMed ID: 14765356
[TBL] [Abstract][Full Text] [Related]
7. Population-based incidence of pertussis among adolescents and adults, Minnesota, 1995-1996.
Strebel P; Nordin J; Edwards K; Hunt J; Besser J; Burns S; Amundson G; Baughman A; Wattigney W
J Infect Dis; 2001 May; 183(9):1353-9. PubMed ID: 11294666
[TBL] [Abstract][Full Text] [Related]
8. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
[TBL] [Abstract][Full Text] [Related]
9. Serological responses to infection with B. pertussis.
Giammanco A; Taormina S; Genovese M; Mangiaracina G; Giammanco G; Chiarini A
Dev Biol Stand; 1997; 89():213-20. PubMed ID: 9272353
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of pertussis in senior adults.
Neuzil KM; Edwards KM; Reed GW
Clin Infect Dis; 2001 Mar; 32(5):847-8. PubMed ID: 11229862
[No Abstract] [Full Text] [Related]
11. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States.
Baughman AL; Bisgard KM; Edwards KM; Guris D; Decker MD; Holland K; Meade BD; Lynn F
Clin Diagn Lab Immunol; 2004 Nov; 11(6):1045-53. PubMed ID: 15539504
[TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of Bordetella pertussis antibody in children and adolescents in China.
Wang CQ; Zhu QR
Pediatr Infect Dis J; 2011 Jul; 30(7):593-6. PubMed ID: 21422963
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a tetraplex microsphere assay for Bordetella pertussis antibodies.
Prince HE; Lapé-Nixon M; Matud J
Clin Vaccine Immunol; 2006 Feb; 13(2):266-70. PubMed ID: 16467336
[TBL] [Abstract][Full Text] [Related]
14. Antibody Specificity Following a Recent
Raeven RHM; van der Maas L; Pennings JLA; Fuursted K; Jørgensen CS; van Riet E; Metz B; Kersten GFA; Dalby T
Front Immunol; 2019; 10():1364. PubMed ID: 31275314
[No Abstract] [Full Text] [Related]
15. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum.
Healy CM; Munoz FM; Rench MA; Halasa NB; Edwards KM; Baker CJ
J Infect Dis; 2004 Jul; 190(2):335-40. PubMed ID: 15216470
[TBL] [Abstract][Full Text] [Related]
16. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
[TBL] [Abstract][Full Text] [Related]
17. Incidence of pertussis in persons < or =15 years of age in Valencia, Spain: seroprevalence of antibodies to pertussis toxin (PT) in children, adolescents and adults.
Diez-Domingo J; Ballester A; Baldó JM; Planelles MV; Villarroya JV; Alvarez T; Carmen Peidró M; Calero P; Garcés MD; Sorribes I; Graullera M; Jubert A; San-Martín M; González A
J Infect; 2004 Oct; 49(3):242-7. PubMed ID: 15337342
[TBL] [Abstract][Full Text] [Related]
18. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses.
Jackson LA; Cherry JD; Wang SP; Grayston JT
Clin Infect Dis; 2000 Jul; 31(1):3-6. PubMed ID: 10913388
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and placental transportation of maternal antibodies specific for Neisseria meningitidis serogroup C, Haemophilus influenzae type B, diphtheria, tetanus, and pertussis.
de Voer RM; van der Klis FR; Nooitgedagt JE; Versteegh FG; van Huisseling JC; van Rooijen DM; Sanders EA; Berbers GA
Clin Infect Dis; 2009 Jul; 49(1):58-64. PubMed ID: 19480581
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of Bordetella pertussis antibodies to pertussis toxin among healthy children.
Syed MA; Ahmed W; Naeem A; Bokhari H
J Coll Physicians Surg Pak; 2012 Oct; 22(10):677-8. PubMed ID: 23058160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
